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Abstract
Bioluminescence Resonance Energy Transfer (BRET), a sensitive, non-destructive and
self-illuminated method, has been now commonly used to test protein interactions. Here,
we describe a BRET sensor for non-invasively detecting glucose molecules. The sensor is
made by the bioconjugation of quantum dots and recombinant protein. The recombinant
protein contains the bacterial glucose binding protein (GBP) and a bioluminescent protein,
Renilla luciferase (Rluc), used as the donor with the emission peak at 470 nm, which is
able to excite the acceptor of BRET sensor made of cadmium tellurium quantum dots (
CdTe QDs) with the emission peak at 570 nm. The distance between the BRET pair
depends on the shape of GBP. In the presence of glucose, the conformational change of
GBP leads to the enhanced BRET phenomenon due to the short distance between the BRET
pair. To optimal the BRET sensor, the ratios of the acceptor (QDs) to the donor (GBPRluc), the bioconjugation process, and the performance of recombinant protein have been
thoroughly investigated. The results indicate a linear relationship between luminescence
intensity ratio and the concentration of glucose in the two ranges, from 0mM to 0.1mM
and from 0.2mM to 0.8mM, respectively. The limit of detection (LOD) is calculated as
15nM. Meanwhile, tear glucose of animal model were measured by this designed sensor.
This study demonstrates a proof-of-concept of a non-invasive measurement system for
monitoring glucose.

Keywords
Bioluminescence resonance energy transfer (BRET), Luciferase, Glucose binding
protein, Quantum dots, Tear glucose.
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Chapter 1

1

General Introduction, Hypothesis and Objective

1.1 Background of glucose sensor for monitoring diabetes
According to the information and data provided by World Health Organization (WHO),
the number of people with diabetes will increase to 366 million by 2030 and at that time,
the diabetes will be the 7th leading cause of death among all other kinds of disease [1].
Diabetes can be divided into 3 main types: type 1 diabetes, type 2 diabetes and gestational
diabetes. Type 1 is a metabolic disorder disease while type 2 is much more related to the
habits of life [2]. Insulin is very important to help maintain the glucose level steady
however for the patients, either their pancreas does not produce enough insulin or the body
cannot use them effectively [3]. To control glucose concentration level is important for
diabetic patients. This is particularly important for patients especially those with type 1
diabetes mellitus, where glucose monitoring can reduce the risk of hypoglycemia, of
cardiovascular disease with microvascular and macrovascular problems and of
neurological abnormalities [4,5]. Carefully controlling blood sugar also prevents patient
death because of losing consciousness and heart failure[6]. Traditionally, glucose
measurements are performed by skin punctures several times regularly throughout the day.
However this method is invasive and results in pain and inconvenience to the patient. It is
also identified that the finger-prick method affects patient compliance with glucose
measurements[7].
Many efforts have been attempted on continuous glucose monitoring devices, which are
normally designed to detect blood glucose levels in real-time based on the measurements
of interstitial fluid glucose concentrations. These devices enabled some improvements in
the self-management of diabetes with reduced hypoglycemia in some extent [8], however,
these benefits are only evident in patients who have recently used an insulin pump, which
can be a more efficient. More generally, the devices still present a number of limitations
such as the poor accuracy and reliability[9]. Thus the devices cannot replace the fingerstick monitoring fully but are well suited to complement the shortage. Also, these systems
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are till invasive as they involve the use of cannula inserted in the subcutaneous tissue of
the abdomen.
Recently, a number of technologies and devices have been proposed and developed for
noninvasively estimating blood glucose concentration. Basically, these technologies focus
on the changes in the chemical and physical tissues properties which caused by the
presence of glucose molecules. These changes can be detected based on optical, chemical
or electrical phenomena, for example via Raman spectroscopy, fluorescence technology
[10], optical coherence tomography [11] and so on. The challenge still lies in the accuracy
as well as the portability of the devices, their safety and their cost [12]. For noninvasive
detection, body fluids such as urine [13-15], sweat [16-19] and tear [20-23] have been
widely used as testing samples. However, the glucose level in the body fluids are much
lower than that in blood for both healthy and diabetic people. In order to accurately test the
extremely low amount of the glucose in body fluids, more sensitive methods have been
developed based on fluorescence resonance energy transfer (FRET) and bioluminescence
resonance energy transfer (BRET).

1.2 Nanostructured Optical biosensors
Types of optical sensors and applications
The development of semiconductors in the 1940s and '50s laid the foundation for the fast
development of optical sensors which lead to cheaper, compact and efficient light-sensing
devices. Nowadays, the applications of optical sensors can be found everywhere in daily
life. Photodetectors were widely used in street lights, camera light meters, and traffic
counters. Fiber optics made the sensitive equipment possible to work in electrically noisy
environments. Sensors packaged with tiny integrated circuits enabled detectors more
convenient to use. Optical sensors have improved efficiency of energy consuming and
reliability of control systems at a more reasonable cost. There are different kinds of optical
sensors and the most common types which we have been using in our real world
applications consists three types[24]. The first is photoconductive devices which can be
used to measure the resistance through converting a change of incident light into a change
2

of resistance. The second is photovoltaic cell or solar cell which can convert incident light
into an output voltage. The third type is photodiodes which convert an amount of incident
light into an output current.
General background of BRET and constructing BRET system
A very important advantage of optical detection methods is their noninvasive properties.
A successful and well-known example of building fluorescent sensor is based on the
modulation of Fluorescence resonance energy transfer (FRET) by Campbell in 2009 [25].
In fact, fluorescence resonance energy transfer (FRET) is widely used in bio imaging since
it was discovered in 1950s [26]. This is the phenomenon of energy transfer between two
light-sensitive chromophores. In this system, the donor chromophore which initially in its
electronic excited stage, may transfer its energy to a nearby acceptor chromophore through
non-radiative dipole–dipole coupling [27]. Though the FRET can be very sensitive with
the distance change, it has limitations. One biggest problem FRET is facing is that the
system requires for external illumination to initiate the fluorescence transfer. This process
may lead to background noise and photo bleaching to the original signal. In order to
diminish the drawbacks, Bioluminescence Resonance Energy Transfer (or BRET) has been
developed to make the assay more reliable [28,29]. This technique uses a bioluminescent
luciferase to be the light source. As it is very sensitive to the distance change, BRET has
been widely used in the area both in vitro and in vivo imaging and biosensor systems [3032]. Fig.1.1 shows the mechanism of BRET.

Figure 1. 1: The mechanism of BRET
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FRET and BRET are both based on resonance energy transfer (RET). The efficiency E, is
defined to represent the quantum yield of the energy transfer transition, which depends on
3 main physical parameters grouped as follows: The distance between the donor and the
acceptor should be very close, generally within the range of 10 nm, the spectral of the donor
emission spectrum should be able to cover the acceptor absorption spectrum and the donor
emission dipole moment and the acceptor absorption dipole moment are relatively oriented
[31].The efficiency E can be calculated by using Equation 1.1.

Eq. 1.1

Where r is the separation donor-acceptor distance and R0 is the Förster distance of this pair
of donor and acceptor.

Furthermore, the Förster distance, R0, is given by equation 1.2:

Eq. 1.2
Eq. 1.2
Where J (λ) is the spectral overlap between donor emission and acceptor absorption, QD
the quantum yield of the donor, n the refractive index of the medium, and κ2 an orientation
factor, which is related to the relative orientation of the donor emission and acceptor
absorption dipole moments. The orientation factor κ2 is one of the most important effectors
to the changes in energy transfer efficiency in both FRET- and BRET-sensors. However,
unlike distance, it cannot be controlled easily. Energy transfer efficiency, E, according to
equation 1.2, not only depends on the distance between the chromophores, but it is also
dependent on the quantum yield of the donor (QD).
A key difference between fluorescence and bioluminescence is the number of photons that
are generated. Thousands of photons per second can be generated when a single
4

fluorophore is excited. However, the light output of bioluminescence is much lower
because the generation of each photon is caused by oxidation of a new substrate molecule.
Most recently, bioluminescence has been used as a reporter gene predominantly, both in
cell-based assays and in small animal in vivo imaging researches[33]. The recent genetic
modification created brighter and more stable luciferases, as well as the concomitant
improvement in luciferase substrates. This development has substantially decreased the
sensitivity gap between fluorescence and bioluminescence. As a result, the use of BRETsensors is no longer limited to intracellular population-based assays, the use for imaging of
single living cells can also be applied, and even emerged as an attractive sensor format for
point-of-care diagnostics[34,35].
An important consideration when designing a BRET-sensor is the choice of the donor
luciferase. Until recently, the most popular luciferases were firefly luciferase and Renilla
luciferase [36]. Luciferases have been found to be important research tools over the last
two decades due to its ability to emit light. Typically, the luciferase from Renilla reniformis
(Rluc) is widely employed in the research area such as molecular biology, using as a
reporter gene in cell culture experiments as well as small animal imaging [37]. To achieve
this bioluminescence, this 36-kDa enzyme Rluc catalyzes its substrate coelenterazine (CTZ)
with the help of molecular oxygen, resulting in the product coelenteramide, carbon dioxide,
and the desired wavelength of light. The catalytic process is shown in Figure 1.2.

Figure 1. 2: Renilla Luciferase catalytic process
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Since the successfully cloning of the gene for Rluc, the gene of Rluc has been incorporated
into a lot of applications of fusion reporter genes, and resonance energy transfer based
sensors [38,39]. A lot of Work has been done using variants of Renilla luciferase to create
novel imaging probes such as fusing the luciferase to engineered antibodies as well as to
generate self-illuminating quantum dots by using the luciferase as a light source [40,41].
Until now, the mutants of Rluc have been widely accepted to replace the native Rluc. The
mutants such as Rluc2 or Rluc8, using as luciferase donor, have achieved great
improvements for luminescence intensity and stability of the assay [42]. However, it has
also been found that the sensitivity of the native Rluc is better compared with Rluc2 or
Rluc8 as the luciferase donor [43]. In this thesis and the following experiment, we thus
choose the native Rluc for our experiment as the luminescence donor.
Limitations of traditional biosensors and the advantages of using nanomaterial
A biosensor is an analytical device to detect an analyte, which combines a biological
component with a physicochemical detector. These analytes can be the original biological
small molecules like DNAs of bacteria or viruses, or proteins generated from the immune
system in infected or contaminated living organisms. The analytes can also be simple
molecules like glucose when a biological receptor unit has the availability with particular
specificity. One outstanding challenge in biosensor development is the signal capture
efficiency of the biological recognition event. Such transducers are able to translate the
interaction of the analyte with the biological element into different forms of signals like
electrochemical, electro-chemiluminescent, magnetic, gravimetric, or optical ones. To
increase the sensitivity as well as lower detection limits down to even single molecules
level, nanomaterials are very promising candidates due to their possibility to immobilize
an enhanced quantity of bioreceptor units at reduced volumes and even to act itself as
transduction element [44]. Among such nanomaterials, gold nanoparticles [45], semiconductor quantum dots [23,31,46], magnetic nanoparticles [47], carbon nanotubes[48],
and graphene[49] based biosensors are intensively studied in the recent years. The
intelligent use of such nano-objects can lead to clearly enhanced performances and lowered
detection limits with several orders of magnitudes. One common advantage of all
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nanomaterials is the high specific surface which enable the packing of an enhanced amount
of bioreceptor units [50].
Quantum dots (QDs), which is one important type of semiconductor nanocrystals (NCs),
are under numerous investigation. One outstanding optical property is that the QDs have
the broad absorption and narrow emission of which the peak positions are tunable by
controlling their sizes and bandwidth [51]. Because of these unique properties, QDs have
affected the area in bioimaging research much more than any other nanomaterial. In the
early eighties, the relationship between band-gap and size of semiconductor materials was
firstly described [52]. But the QDs was not established as a new kind of fluorophores in
the area of biological research until 1998, when two articles published in Science indicated
the advantages of using QDs for biosensing [53,54]. In the following years QDs received
blooming research for their applications in biological macromolecule sensing, cell staining,
bioconjugation and in vivo imaging [55-57].
CdTe is one types of the particular high quality QDs which consists of II/VI
semiconductors. This nanocrystalline QD can be synthesized by capping different ligands
and has great potential in the applications of biological probes and optoelectronic devices
[58]. Wet –chemical synthesis of the nanocrystals (NCs) in colloidal solution is one of the
most effective methods to obtain NCs with both high photoluminescence quantum yields
and tunable shapes [59]. Three main approaches for producing QDs are: organic phase,
water-phase, and two-phase. Compared to organic and two-phase approaches, the aqueous
solution preparation method has gained much more research interest as it is simpler to make,
has less toxicity, and more environmentally friendly. Furthermore, the products also have
improved water-stability as well as biological compatibility [60].

1.3 Hypothesis
The detection of glucose level in tear has been long-timely studied and the main challenge
still lies in the accuracy of the detection as the glucose level in tears which is much lower
than that in blood. Most fluorescence sensor requires external light source which may be
not suitable for in vivo test. Bioluminescence Resonance Energy Transfer (or BRET)
7

technique is a distance non-radiation process, and does not require external energy source
could be applied for the non-invasive glucose sensor. BRET has been developed to make
the assay more reliable [28,29]. This technique uses a bioluminescent luciferase, typically
the luciferase from Renilla reniformis to be the light source [39,41,61]. In order to test the
extremely low concentration of glucose from the tiny amount of the tear sample, and to
minimize the drawbacks of fluorescence sensors, we are proposing a bioluminescence
resonance energy transfer (BRET) sensor for non-invasively detecting glucose molecules.
The sensor is assembled by conjugating quantum dots CdTe (emission wavelength, λem ≈
565nm), which is used as the acceptor, with a recombinant protein containing the bacterial
glucose binding protein (GBP), at the N-terminal and a bioluminescent protein Renilla
luciferase (Rluc), used as the donor, which is at the C-terminal. The BRET emission of
the designed sensor is weak because the distance between the BRET pair is relatively far.
In the presence of glucose, GBP binds glucose because of their strong interaction and leads
to the conformational change of GBP, which results in the short distance between the Rluc
and QDs, and, therefore, the emission intensity of the QDs increases due to the BRET
mechanism. In my study, the recombinant protein was further expressed and purified from
bacteria Escherichia coli BL21. Meanwhile, quantum dots used as the acceptor can be
labelled on the N-terminal of the recombinant protein. Fig. 1.3 shows the illustration of the

Figure 1. 3 : The scheme of the BRET biosensor. QDs were used as the BRET
acceptor and Rluc was the donor. GBP was at the middle site and will fold in the
presence of glucose molecules.
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BRET sensor made of three parts, (1) quantum dots used as an acceptor in the BRET sensor
(2) glucose sensitive protein GBP acting as the sensing element; (3) Rluc used as a donor
in the sensor.

1.4 Thesis objectives
BRET is an inexpensive and very sensitive method for detecting the biomolecule
interaction because of the correspondence of BRET intensity to the change of the distance
between the biomolecules. Here, the goal of this thesis is to build a non-invasive and very
sensitive biosensors by applying the BRET mechanism to test the level of glucose
concentration; different body fluids including blood and tear are used to evaluate the
performance of the designed sensor. A brief summary of the steps to achieve the goal is
listed as follows:
•

To synthesize and modify carboxylic groups coated CdTe QDs. Since the CdTe
QDs will be used as the acceptor in the BRET pair, which will also be bioconjugated
with hydrophilic protein, the quantum dots is prepared in aqueous to have the
improved water-stability as well as biological compatibility.

•

To construct the recombinant plasmid and purify the target protein, including
design the recombinant DNA and purify the His-tag protein through His-trap
column.

•

To bioconjugate the recombinant protein onto the CdTe QDs and to optimal the
assay for glucose sensing.

•

Characterization of the CdTe QDs, the recombinant protein and the bioconjugation
products.

•

To evaluation of the performance of the designed BRET biosensor by using
aqueous sample and animal model.

1.5 Thesis overview
An overview for the thesis is presented as follows:
9

Chapter 2 Literature review
This chapter reviews the current glucose detection methods, the methods of
hydrophilization of QDs, the genetic engineering of luciferase and the derivations of the
substrates, the bioconjugation methods of QDs with biomolecules in constructing
biosensing systems.
Chapter 3 Experimental
This chapter describes the methods used to synthesize TGA-coated CdTe QDs in aqueous
phase, the construction of recombinant DNA and the transformation of the recombinant
plasmid, the expression and purification of the recombinant protein. In addition, various
characterization techniques and methods which have been used in the experiment are
briefly explained in this chapter such as FT-IR and UV-Vis. The SDS-PAGE test,
photoluminescence test and bioluminescence test are also mentioned here.
Chapter 4 Development of the acceptor of the sensor made of CdTe QDs and recombinant
protein of GBP-Rluc
This chapter focuses on the development of the CdTe QDs used as the acceptor of the
sensor, the sensing element, GBP, for glucose and Rluc acting as, and the donor of the
sensor. First the synthesis surface modification of suitable CdTe QDs were investigated
and analyzed by FT-IR. Secondly, recombinant protein of GBR-Rluc was constructed.
SDS-PAGE was carried out to test the recombinant protein. The properties especially the
bioluminescence efficiency was also studied here to find out the optimal conditions (ratio,
buffer and time) for the bioconjugation.
Chapter 5 BRET biosensor construction and evaluation
Chapter 5 focuses on the integration of the acceptor of QDs and the recombinant protein
GBP-Rluc. This Chapter also provides the results on developing nanostructured BRET
sensor. The performance of the designed BRET sensor were evaluated in vitro. The BRET
donor, recombinant protein GBP-Rluc was conjugated on the BRET acceptor, TGA-coated
CdTe QDs. The effect of the amount of EDC and the ratio of the recombinant protein to
the acceptor and the bioconjugation processes on the glucose sensing performance were
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studied. The BRET intensity ratio as a function of the concentrations of aqueous glucose
were presented in this Chapter, In addition, the performance of the designed BRET
biosensor was evaluated by the tear glucose of diabetic rats.
Chapter 6 Summary and future work
This chapter draws a conclusion of this study and addresses on the integration methods of
three key parts of the sensor. Future work regarding the improvement of BRET biosensor
for glucose detection are discussed.
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Chapter 2

2

Literature review

2.1 Quantum dots based biosensor for glucose detection
The accurate in situ detection of glucose has long been studied a lot due to its important
role in the diagnosis of diabetes mellitus. Currently the commercialized glucose
measurement device for diabetic patients are based on enzyme glucose oxidase [1,2].
However, the instability and high cost of such sensors are still serious problems.
Accordingly, a lot of research has been done in developing synthetic reagents for
monitoring glucose.
Quantum dots (QDs) have attracted a great deal of interests due to their high photostability,
continuous absorption spectra, and size-controlled fluorescence properties [3-5]. Recently,
some typical researches have been done in QDs coupled with boronic acid-based ligands
for glucose detection in optical methods. In 2006, Singaram and his colleges were the first
to utilize QDs for glucose sensing[6]. In their research, the fluorescence of CdTe/ZnS QDs
was quenched by boronic acid-substituted viologen, while it could be recovered by
introducing glucose to the quenched QDs solution. Later in 2009, Willner and coworkers
developed a competitive assay for glucose by applying fluorescence resonance energy
transfer (FRET) mechanism between phenylboronic acid-functionalized CdSe/ZnS QDs
and fluorophore-labeled galactose molecules [7]. Zhou and coworkers prepared
phenylboronic acid-modified CdTe/ZnTe/ZnS QDs for determining the intracellular
glucose level in 2010 [8]. In their work, the QDs were found to be able to get selfassembled when glucose molecules were introduced, resulting in the fluorescence
quenching of QDs. As boronic acid is widely used as ligands in constructing quantum dots
based sensing system, the derivatives of boronic acid were also attracted attentions. As it
is well known that both boronic acid and its derivatives are capable of forming reversible
covalent complexes with 1,2- or 1,3-diols, such as glucose [9], glucose biosensor can be
built with the resulting complexes based on fluorescent[8,10,11], holographic[12,13] and
electrochemical methods [14]. Also by applying FRET quenching mechanism, a
nanostructured biosensor was developed to detect glucose in tear by using CdSe/ZnS
quantum dots (QDs)as FRET donor, and dextran-binding malachite green (MG-dextran)
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as the acceptor, which was conjugated to an enzyme with specific affinity to glucose named
concanavalin A (Con A) [15]. Compared to the semiconductor quantum dots, graphene
QDs are also attracting considerable attention because they can be replaced the traditional
QDs due to their chemical inertness, low toxicity biocompatibility. Graphene QDs can be
obtained by effectively adjusting the band gap of graphene to convert the 2D graphene
sheets into 0D. Graphene quantum dots broad the way in designing reagentless biosensors
using direct electron transfer of immobilized enzymes on conducting substrates [16-18].
As graphene has the ability to promote electron transfer reactions, it has been widely used
as an electrode material [19,20]. Thus, various redox proteins or enzymes can be coupled
with graphene based materials to construct third generation electrochemical biosensors
[21,22]. A typical example is to immobilize glucose oxidase on graphene QD modified
carbon ceramic electrode to build a glucose biosensor [23]. The developed biosensor can
respond to glucose presence over the concentration range 5–1270μM with the detection
limit at 1.73μM and sensitivity at 0.085μA μM-1 cm-2. Similarly, a fluorescent biosensor
for blood glucose monitoring is also developed based on hemin-functionalized graphene
quantum dots and glucose oxidase system with a detection limit at 0.1μM [24].

2.2 Surface modification (hydrophilization) of QDs
Photoluminescence QDs are one of the most popular candidates for biomedical
applications such as therapeutic labeling, bioimaging and biosensing. For these typical
applications, the particles should meet some basic requirements, for example, QDs should
be stable and maintain their optical properties in aqueous solutions with a tolerance in wide
range of pH. Also, to label QDs with other biomolecules, it should have functional groups
on the surface for conjugation. The traditional synthesis of QDs were generally resulted in
very hydrophobic nanoparticles. In this case, the QDs will only be soluble in non-polar
solvents and are limited in biomedical applications. The phase exchange of QD from
organic solvents to water phase is usually accompanied with the decrease of the QY [25].
In order to improve the usage of QDs, the surface modification of QDs thus need to be
explored [26]. There are mainly three strategies for transferring oil-phased QDs into waterphase: by ligand exchange, silanization, and encapsulation, as indicated in figure 2.1.
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Figure 2. 1: Three main methods of hydrophilization of QDs

2.2.1

Ligand exchange and silanization

The first method involves ligand exchange, in which the original hydrophobic coating (e.g.
trioctylphosphine oxide (TOPO)) is removed and replaced by water-soluble bifunctional
molecules. The one end of the bifunctional molecules is attached to the QD surface and the
other end is a hydrophilic tail thus makes the QDs available for further bioconjugation. The
process is due to the surface group such as thiol, amine and carboxyl, which can passivate
QDs more strongly than the original ligands[27]. Other examples of linker molecules such
as dithiothreitol (DTT), 2-aminoethanethiol and dihydrolipoic acid (DHLA), can be
mentioned [28]. The second method is called silanization, which actually can be seen as
one form of ligand exchange strategy, but can be highlighted separately due to its
prevalence[29]. The possibility of coating of a single QD in a silica shell is due to the nontoxic, chemically inert and optically transparent properties of the silica surface. The silica
surface can not only protect the nanoparticles from been oxidized as silica matrix can
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provide nanocrystals with an enhanced colloidal stability resist to the environment, it also
protects the QD from leaching components (e.g. Cd). In addition, the silica based material
is biocompatible thus can be functionalized for bioconjugation.[30,31].

2.2.2

Encapsulation

The third method is to encapsulate the hydrophobic nanoparticles into different carriers
such as amphiphilic polymers [32], polymeric microbeads [33] or liposomes [34]. The
hydrophobic shell of QDs have physical interactions with the original coating molecules,
which makes the surface modification of QDs possible. Up to now, a number of
amphiphilic copolymers and polyelectrolytes have been synthesized for modification [3537]. The QDs can also be treated with surfactant, but because of the relatively weak
anchoring interactions, the result product cannot be stable in biological environment for a
long time. These problems can be solved by applying amphiphilic polymers into the system.
Due to the multiple hydrophobic and hydrophilic units on the surface, it can have a strong
interaction with the QD surface [38]. Liposomes can also be used in the encapsulation
process as spherical lipid vesicles. Because of their porous spherical structure and high
loading capacity, liposomes are very popular carriers for hydrophobic QDs [39]. The
encapsulation of QDs into liposomes has some advantages, for example, it can help with
the bioconjugation between QDs and the biomolecules such as proteins and enhance the
analytical signal [40]. However, using liposomes as carrier vehicles has some drawbacks
because it is not stable in vivo and easily be affected by the external environment such as
the temperature and pH [41]. The best way to solve this problem is through coverage or
templating them with polymer materials [42].

2.3 Bioconjugation of QDs with biomolecules
Covalent linking and non-covalent binding are the two main approaches to immobilize
biomolecules on the QD surface. Non-covalent binding is mediated by the typical
interactions between biomolecules and the QD surface, while covalent linking is obtained
through the chemical reactions of the molecular surface groups [43,44]. The history of
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bioconjugation of QDs can date back to 1998, when Bruchez and Chan were the first
scientists who successfully conjugate QDs to biomolecules[45,46]. After that, the usage of
QDs in imaging and other biomedical applications has been greatly studied and explored.

2.3.1

Non-covalent binding

Non-covalent attachment of biomolecules to the QD surface has two based types of QD
surface-biomolecule interaction, which are electrostatic interaction between oppositely
charged molecules and high affinity secondary interactions. Bioconjugation through
electrostatic interaction is simplest and most popular non-covalent approach as there is no
chemical reactions taken place. The mechanism of the electrostatic interaction is the
attraction between oppositely charged species on the surface of QDs and the biomolecules
for conjugation [43]. A popular method of electrostatic coupling of proteins with QDs is
through interactions between the negatively charged surfaces of QD and the positive
charged surface of a protein [47]. Another class of non-covalent binding is secondary
interactions between functional groups on the surface of QD and the surface of
biomolecules. Biotin-avidin interaction is most used for high affinity interactions such as
DNA interactions or enzyme-substrate interactions. However, though the bioconjugation
of QDs via biotin-avidin process is prevalence, the bioconjugated products are generally
very large in size, which makes it less popular than EDC-mediated covalent conjugation
chemistry. The smaller size of products can be more useful in targeted applications such as
fluorescence resonance energy transfer (FRET) and cellular research [47,48]. The strong
interaction between His-tagged biomolecules and Ni-NTA (NTA-Ni2+-His) is also a wellknown kind of high affinity secondary interaction and is widely used for bioconjugation
process [49]. This strategy has also been used to develop a QD-probe for performing
Western blot analysis. Compared to the classical Western blot, this new approach has a
shorter analysis time but a better sensitivity [50]. A less popular strategy is based on the
barnase-barstar system designed for Ig multimerization but later developed to a scFv(barnasebarnase) fusion protein, which allows binding of the scFv Ig to the QDs [51].
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2.3.2

Covalent binding

Covalent conjugation between QDs and molecules involves the reaction of the functional
groups between the QDs and the target biomolecules. The covalent binding strategy is
determined by what kind of groups are on the surface of the QDs and the biomolecules.
The surface modification of the target biomolecules is sometimes hard to achieve, while
the surface modification of QDs is relatively easy as it can be determined by different
hydrophilization strategies mentioned above. Covalent binding can be achieved by the
usage of functional crosslinkers. Crosslinkers are different in the linker length thus they
can be used for different design purpose.

Figure 2. 2: DSP mediated conjugation of amine containing QD with protein
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The smallest available crosslinkers for bioconjugation are so-called zero-length
crosslinkers (e.g. EDC and N, N′-Dicyclohexyl carbodiimide (DCC)) because these
compounds mediate the conjugation of two molecules directly by adding no additional
atoms. Dithiobis succinimidylpropionate (DSP) is other popular homo-bifunctional
crosslinking reagents used for bioconjugation. The mechanism is the DSP can connect two
molecules with the same functional group on both ends of an alkyl spacer (Fig. 2.2). An
obvious disadvantage is the potential of creating a range of conjugates as the reaction is
non-specific thus these conjugates can further react with other functional groups, results in
a mix conjugates. To avoid or reduce this problem, homo-bifunctional groups were used to
develop two-step procedures [52].

Figure 2. 3: SMCC mediated bioconjugation between amine containing
QD and thiol containing protein
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Heterobifunctional crosslinkers such as SMCC (succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate) contains two different reactive groups, allowing coupling of
two different functional molecules. As shown in Fig. 2.3, the QDs part may contain an
amine reactive group, while the target protein may consist of a thiol-reactive group.
Carboxylic functionalized QDs are now the most popular commercial available ones. The
carboxylic groups can be easily conjugated to free amine groups, which are quite common
on the surface of proteins, peptides or Igs molecules [53]. In this method, no additional
chemical modifications of the proteins are needed before conjugation, which makes the
process easy and fast [44]. EDC is the most well-studied and easy-to-perform method for
zero-length crosslinking the biomolecules onto QDs [54,55]. The terminal carboxyls on the
QDs and amines on the biomolecule (e.g. proteins) directly form into amide bond by the
mediation of EDC, although the reverse configuration may work equally in some cases
[43]. Apart from carboxylic groups, amine groups are the second most popular functional
groups for bioconjugation. A lot of heterobifunctional crosslinkers have been employed for
bioconjugation of QDs- NH2. Conjugation of QDs-NH2 can be more selective if reacted
with biomolecules containing thiol groups. As cysteine and methionine are the only two
amino acids that contain thiol groups, other side reactions thus can be prevented [56].

2.4 Molecular bioluminescence in biomedical studies
2.4.1

Luciferases and their genetic mutants for constructing BRET
system

Luciferases are mainly from the North American firefly Photinus pyralis, the click beetle
Pyrophorus plagiophthalamus, the sea pansy Renilla reniformis and the marine copepod
Gaussia princeps. Those are the most popular types of proteins used for bioluminescence
tomography, however, their substrates are different due to the living environment. Dluciferin is the substrate for terrestrial organisms luciferases while coelenterazine analogs
are used as substrates by marine organisms’ luciferase, as summarized in Table 1 [7–23].
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Table 2. 1: Luciferase reporters used for bioluminescence tomography and their
specifications
Bioluminescent reporter

Emission peak

Size (kDa)

Substrate

Refs

Luciola italica red;

~620 nm

64

D-Luciferin

[57]

Photinus pyralis red;

618 nm

62

D-Luciferin

[58]

Photinus pyralis; North

~600 nm

62

D-Luciferin

[59]

Rluc 480 nm

36

Coelenterazine

[60]

Rluc8 480 nm

36

Coelenterazine

[61,62]

Rluc8.6 535 nm

36

Coelenterazine

[61,62]

480 nm

20

Coelenterazine

[63]

460 nm

19

Furimazine

[64]

~460 nm

62

Cyprinidid

[65]

American firefly luciferase
Renilla reniformis; sea
pansy luciferase

Gaussia princeps; Gaussia
luciferase
Oplophorus gracilirostris;
NanoLuc luciferase
Cypridina noctiluca;
Cypridina luciferase
Vargula hilgendorfii; sea

luciferin
~460 nm

62

firefly luciferase
Aequorea Victoria; aequorin

Cyprinidid

[66]

luciferin
~460 nm

62

Coelenterazine

[67,68]

photoprotein

Research on novel luciferase genes and their mutants has reached great improvement over
the past decade. The new NanoLuc luciferase, which is only19.1 kDa, attracts the most
interests among the luciferases that use coelenterazine analogs. NanoLuc was isolated from
a deep-sea shrimp and the substrate is a novel coelenterazine analog named furimazine.
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The difference between coelenterazine and furimazine is the phenol group replaced by a
furane, as indicated in Fig.2.4.

Figure 2. 4: Chemical structure of coelenterazine and its analog, furimazine.

This luciferase-substrate system has now also been successfully applied to in vivo
bioluminescence imaging due to the high-intensity and glow-type luminescence it provides
[64,69]. In addition to developing improved mutant genes alone, the luciferase gene can be
designed to combine with other reporter genes. For example, intramolecular
bioluminescence resonance energy transfer (BRET) systems can be established by
coupling the luciferase with nanoparticles [70]. The fusion of enhanced Renilla luciferase
and the fluorescent protein Venus is a very typical example of applying this technic into
Nano-lantern applications. The novel Nano-lantern system can enhance the in vivo
performance compared with using Renilla luciferase alone [71]. In addition, a more
efficient near-infrared BRET systems for deep-tissue imaging can be developed by fusing
Renilla with near-infrared fluorescent proteins (iRFPs) [72]. Another type of engineered
probes using BRET phenomenon is bioluminescent quantum dots in vivo imaging. To
construct the system, a bioluminescent protein is covalently attached with quantum dots
but the distance may change in the presence of analyte. A sequential BRET-FRET energy
transfer system can be built with multiple donors or acceptors by using this strategy. A
typical example in recent study is combining firefly luciferase variants with near-infrared
quantum dots, which resulted in high BRET efficiencies [73,74].
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2.4.2

Luciferase substrates and the derivations

A recent study revealed that phenolate-luciferin-binding site interactions modulate
bioluminescence colors by studying two different substrates, NH2LH (amino luciferin) and
its 5, 5- dimethyl analog Me2NH2LH [75]. The modification of D-luciferin or aminoluciferin at the 6’ position not only affect the spectral of the emission but also the emission
intensity. Compared with unsubstituted 6’-aminoluciferin, the bioluminescence emission
of analog N-alkylated 6’-aminoluciferin has been identified to be more efficient when
catalyzed by both wild-type and mutant P. pyralis luciferase [76]. When replacing the Dluciferin sulfur atom at position 1 with selenium (Fig. 2.5), the emission will shift to red
without changing luciferase types [77]. Furthermore, it has also been found that luciferin
analogs that have conjugated double bonds between the thiazoline ring and the aromatic
moiety tend to shift to red but the light intensity will drop in some extent [78]. Remarkably,
the P. pyralis firefly luciferase can produce near-infrared light when using a dual-color
firefly luciferin analog, infra-LH2 (iLH2), as the substrates [79]. Using the same approach,
Aka-lumine hydrochloride (Aka-lumine-HCL) has been developed with a maximum
emission at 675 nm (Fig. 2.5) [80].

Figure 2. 5: Bioluminescent Substrates. Chemical structure of firefly luciferin and
different analogs.
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Chapter 3

3

Experimental Methods

3.1 Preparation of thioglycolic acid (TGA) coated CdTe QDs
The colloidal CdTe QD solution was prepared based on the method described elsewhere.
[1] Briefly, in a three-necked flask, 0.4mmol Cd(CH3COO)2∙2H2O was totally dissolved
into 60 ml deionized water. 10 mins after the solution is clear, 36μl TGA was added into
the solution. After stirring for 5 min, 0.08mmol Na2TeO3 which was dissolved in 50 ml
deionized water was added into the above solution. Keep stirring for 3mins and then 160
mg of NaBH4 was added into the precursor solution, the pH was adjusted with 1 M NaOH
solution to 11. Then the three-necked flask was refluxed at 100 ℃ with a condenser
attached under open-air conditions. The QDs with desired PL emission spectra can be
obtained through controlling the reaction time.[2] The QDs nanoparticles were washed
twice by isopropanol and finally dissolved in deionized water.

3.2 Plasmid construction for GBP-Rluc
The mglb gene originally from E. coli k-12 that encodes for wild-type GBP is used for
plasmid construction. Bacterial glucose binding protein (GBP) was cloned Rluc gene was
cloned from the plasmid pRL-null (Promega, Inc). A six amino acid linker was inserted to
link the two proteins. Four primers were designed for construct the GBP-Rluc recombinant
protein.

For

GBP,

two

primers

were

designed

for

TATACATATGAATAAGAAGGTGTTAACCCTGTCTGC
GCTGGATCCTTTCTTGCTGAATTCAGCCAGGTTG

Cloning
3′;

(forward

reverse

5′
5′

3′). The forward and reversed

primers were introduced restriction site Nde I and BamH I (restrict enzyme) respectively
(underline). In order to separate the sequence of GBP from that of Rluc, a six amino acid
linker SGGGGS (bold underline) was inserted after BamH I site (underline) when
designing

the

forward

primer

to

amplify

Rluc

(

5’

AAAGGATCCAGCGGTGGTGGTGGTAGCATGACTTCGAAAGTTTATGATCCAG
3’)
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The reverse primer for Rluc (5’TGTGCTCGAGTTGTTCATTTTT GAGAACTCGCTC
3’) introduced restriction site Xho I (underline). The GBP is thus located at the upstream
(N-terminal) of the fusion protein.
The above PCR products were further digested with relating restriction enzyme. The
plasmid pET32a (Novagen, Inc) was used to clone and express the recombinant gene. The
digested DNA insert were ligated into the relating MCS (multiple cloning) site at pET32a.
A six histidine tail was introduced into the GBP-Rluc recombinant protein. The pET 32aGBP-Rluc was transformed into E. coli BL21 cells. The DNA sequence of the recombinant
plasmid was confirmed by DNA sequencing (Robarts Institute, Western University).[3]

3.3 His-tag recombinant protein purification
3.3.1

Bacterial culture

Choose the single colony on the agar plate which contains the bacterial cells with desired
recombinant plasmid pET32a-GBP-Rluc with a loop. Insert the loop into 5ml of Luria
Bertani (LB) borth containing100 μg/mL ampicillin and let the bacterial grow overnight at
37 ° C. This culture was for the preparation of further inoculate 800 mL of broth containing
100 μg/ml ampicillin, which was also left to grow at 37° C. When the culture reached an
OD600 of 0.375, Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added into the
solution to 1 mM for the final concentration to induce the expression of GBP-Rluc. After
adding the IPTG, the bacteria were left to grow for another 4 hrs at room temperature with
shaking at 200rpm.

3.3.2

Harvest the protein

After 4 hours expression, the bacterial cells were harvested by centrifugation at 9,000 rpm
for 5 min at 4° C. The supernatant was then discarded and the pellet was then re-suspended
in a binding solution (BS), which contains 20 mM Tris/HCl, pH 7.4, 500 mM NaCl and 5
mM imidazole. Repeat the re-suspend steps at least once and then add Triton X-100 into
the solution at a final volume of 0.5% (Sigma-Aldrich, Inc.). After gently shaking for 5mins,
37

10mg lysozyme which was pre-dissolved in Binding solution was added into the bacterial.
The tube containing the above solution was then transferred to a 20ml beaker and sonicated
on ice using 5-s bursts followed by 9-s rest for at least 50 cycles using a Mandel Scientific
Q500 sonicator (Guelph, Canada).

3.3.3

Protein loading and elution

After the sonication, the suspension was centrifuged at 8,000 rpm at 4° C for 30 min to
collect the supernatant from bacterial cell pellet. The protein solution was then transfer to
a clean tube and filter the solution again by cellulose acetate membrane syringe filter (VWR,
Inc.) which the pore size is at 0.45μm. The collected protein solution was purified via Histrap HP columns (GE lifescience, Inc.) by a syringe pump. The column was first prepared
with Binding Solution to be equilibrated.
The supernatant containing the protein was loaded into the column at a low speed of
0.3ml/min and the column was washed with 10 column volumes of the Binding Solution
(BS). To test the best concentration for washing out the target His-tag protein, the protein
was eluted using BS with seven gradients of imidazole (20mM, 40mM, 60mM, 80mM,
100mM, 120mM and 150mM) over 10 column volumes at a mediate speed at 0.5ml/min,
respectively. Each flowing through solution was collected and the fractions in each tube
were around 8 milliliters. The column was then washed with 10 column volumes of DDW
and then the same volumes of ethanol. Wash the column with DDW again before putting
them into 4℃ for storage.

3.3.4

Identification by sodium dodecyl sulfate polyacrylamide gel
electrophoresis

Sodium dodecyl sulfate polyacrylamide gel electrophoresis (10% SDS-PAGE under
reducing conditions and stained with Coomassie Blue) was used to verify the purity and
the expression extend of each fractions containing the target protein.
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For SDS-PAGE samples preparation, mix the protein from different fractions mentioned
above in a ratio of 4:1 with the sample buffer and then heat the sample by boiling for 5-10
minutes in a water bath.
After solidification of the gel, the protein marker (Bio-rad, MW size range 10–250 kD)
was added into the first well and the frictions of protein mentioned above were added into
the wells from a low concentration of imidazole to higher range. The gel was running in
SDS Running buffer at 100 V for 20 min and then increased to 150 V for 40mins in order
to fully separate the recombinant protein. After 1hr, the gel was taken out and immerged
into staining buffer in a box. The box containing the gel was anchored on a shaker with a
speed of 60 rpm and incubated for 40mins.
After 40mins, the gel was gently taken out and then immerged into 1L distaining solution
which was made up by mixing 100 mL methanol and 100 mL acetic acid in 800 mL DDW.
After 4hrs shaking at a speed of 50 rpm, the gel was taken out gently for observation.

3.3.5

Dialysis of the recombinant protein GBP-Rluc

After getting the target fractions from different tubes, the fractions were collected into a
new tube. Excess imidazole was removed from the combined fractions by buffer exchange
with excess amount of 3 different buffers: 10 mM Tris/HCl, pH 7.4, 10mM PBS, pH 7.4,
10mM Borate, pH 8.0, respectively with adding the extra glycerol in a concentration of
0.5% in order to maintain the recombinant protein into different buffer for further testing.

3.3.6

Concentrate target protein

The above fractions were collected and concentrated using an Amicon Ultra centrifugal
filter (ultra-15, MWCO 10 kDa, Millipore Inc). The resultant GBP-Rluc protein solution
was stored at −20° C. The concentration of the protein was determined by Bicinchonici
acid (BCA) protein assay (Thermo scientific Inc.)
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3.4 Bioluminance performance of GBP-Rluc
To optimize the experimental conditions for the QD-GBP-Rluc assay, the best conditions
for the bioluminescent performance of GBP-Rluc has to be tested. Here we tested the
performance of GBP-Rluc dissoveld in different buffers: 10 mM Tris/HCl, pH 7.4, 10mM
PBS, pH 7.4 and 10mM Borate, pH 8.0, respectively. The ratio of GBP-Rluc and the
substrate, native CTZ were tested by adding different amount of CTZ (3ul, 5ul, 7ul and
10ul in 1mg/ml) into 0.1mg protein dissolved in PBS solutions. The effect of protein
concentration was also tested by adding 5μl CTZ (1mg/ml) into a gradient concentration
of protein solution from 0.01mg to 0.4mg. As the bioluminescence is not very stable and
decay with time [4], the performance of GBP-Rluc was tested by adding 5μl CTZ (1mg/ml)
into protein solution to find the relationship between the intensity change and time. All of
the bioluminescent emission spectra were collected by a Quanta Master™ 40
Spectrofluorometer (HORIBA-PTI Inc., London, ON).

3.5 Bioconjugation of TGA-CdTe QDs by GBP-Rluc protein
and optimization of BRET sensor
The bioconjugation was mediated by 1-ethyl-3-(3-dimethylami-nopropyl) carbodiimide
(EDC). In a typical experiment, TGA Stabilized CdTe (10μl at 2μmol/L) and EDC (10μL
at 20mmol/L) were mixed in 80μl PBS. After the mixture were gently shaking for 10 min
at room temperature, 50μl of 0.1mmol/L protein was added into the above solution and
incubated for another 10min. Afterwards, 2μL of ethanolamine was added to stop the
reaction. The particles were further purified by amicon ultra-0.5 filter (100kDa, MWCO,
EMD MilliporeInc.) to remove free GBP-Rluc and other small molecules.

3.6 Characterization
The TGA-coated CdTe QDs were verified by using Fourier transform infrared (FTIR)
spectrophotometer (BrukerFTIR-IFS55, Germany). The size and the absorbance peak of
the nanoparticles were confirmed by UV-Visible Spectroscopy (UV-3600 Shimadzu,
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Japan). Bioluminescent emission spectra were collected by a Quanta Master™ 40
Spectrofluorometer (HORIBA-PTI Inc., London, ON) with the step size at 0.1s.

3.6.1

Fourier transform infrared spectroscopy

FTIR is a technique based on the theory that each chemical group has characterized
absorption infrared spectrum. In the measuring process, the FTIR instrument shines a beam
with different frequencies of light at once, and then adsorbed by the sample. Next, the beam
is modified to contain a different combination of frequencies, generating a second data
point. This process will repeat. Afterwards, a computer analyze all these data and transfer
what the absorption is at each wavelength by using a common algorithm called the Fourier
transform. In this project, the chemical groups on the surface of quantum dots were
characterized by FTIR.

3.6.2

Ultraviolet – Visible spectroscopy

Ultraviolet-Visible spectrophotometry (UV-Vis) refers to absorption spectroscopy and
reflectance spectroscopy in the ultraviolet and visible spectral region. The light ranges from
near-UV to near-infrared ranges. The absorption or reflectance in the visible range directly
affects the perceived color of the chemicals involved. In this region of the electromagnetic
spectrum, molecules undergo electronic transitions.[5] UV-Vis was carried out to confirm
the absorbance of selected quantum dots and to check the size of the synthesized CdTe
QDs. UV-Vis is also used to calculate the concentration of the quantum dots solution.

3.7 Glucose assay
The above GBP-Rluc-QDs conjugate solution was diluted to 400μl by PBS and then treated
with 3μl of aqueous glucose with different concentrations from 0mmol/L to 1mmol/L. The
mixture was gently shaken for 2min at room temperature. The fluorescence emissions were
then measured from 410nm to 640nm by the fluorometer immediately following addition

41

of 5μL of native CTZ (1mg/mL, dissolved in ethanol) to the above assay solutions. Each
concentration of glucose was tested for three times.

3.8 Animal tear test
Rats with diabetes were used to get the tear sample and the process was reported
elsewher[6]. Briefly, Male Sprague-Dawley rats, eight-weeks of age, were obtained from
Charles River Laboratories. Rats were housed two per cage at constant temperature and
humidity on a 12-h dark/light cycle, and had access to water and standard chow ad libitum.
Ethics approval was obtained from the University of Western Ontario Research Ethics
Board, in accordance with Canadian Council on Animal Care guidelines. The experimental
protocol followed the Principles of Laboratory Animal Care (US NH publication No83-85,
revised 1985). Rats were housed for one week to familiarize with their surroundings prior
to the initiation of experiments.

Diabetes was induced with multiple low-dose

Streptozotocin (STZ) injections. STZ (20 mg/kg; Sigma Aldrich, Oakville, ON, Canada)
in citrate buffer was injected into the intraperitoneal cavity for five consecutive days (1).
Diabetes was confirmed by two consecutive non-fasting blood glucose readings of
≥18.0mmol/L. The blood glucose level of three male Sprague-Dawley rats were tested
before collecting the tear. Tear fluid was collected from the ocular surface with a 1 μL glass
capillary tube (P1424 SIGMA). 1 μL of rat tear sample were collected from each male
Sprague-Dawley rats from the ocular surface with a 1 μL glass capillary tube (P1424
SIGMA). The tear samples were diluted by PBS pH 7.4 to 10μL. To keep the same amount
and the procedure of the BRET sensor measurement, 3μL of the diluted sample was used
to measure the glucose level by BRET sensor with 3 independent tests. Ethics approval
was obtained through the University of Western Ontario Research Ethics Board, in
accordance with Canadian Council on Animal Care guidelines.
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Chapter 4

4

Development of the acceptor of the sensor made of QDs
and recombinant protein of GBP-RLuc

QDs has been widely used in bioimaging and biosensing in the recent years as it has unique
properties like strong fluorescence intensity, high stability and good biocompatibility [13]. In this chapter, the photoluminescence of CdTe was characterized and FTIR was used
to identify the surface groups of CdTe. The successful purification of the recombinant
protein was identified by SDS-PAGE. The bioluminescence property of GBP-Rluc was
tested under different conditions including the ratio with substrate, buffer and time.

4.1 Introduction
Quantum dots are under heavy investigation due to their tunable emission peaks by
controlling their sizes and bandwidth. The unique optical properties and good
biocompatibility make it a very suitable kind of candidate in bioimaging and other
biomedical fields [4,5]. CdTe QDs is a particular high-quality kind of QD consisting of
II/VI semiconductors which has widespread applications in the biosensing filed [6,7]. The
wet-chemical preparation was one of the most successful methods to obtain nanocrystals
with both high photoluminescence quantum yields (PL QYs) and tunable sizes and shapes
[8,9].
Wet-chemical synthesis of QDs can be divided into water-phase, organicphase and twophase approaches. Among them water-phase preparation attracts most interests as it is
relatively simpler, less toxic, and more environmentally friendly. Furthermore, the
products have enhanced water-stability and biological compatibility[10].
In this paper, we used a simple and economical one-pot method to prepare highly
luminescent water soluble CdTe QDs which has been reported in 2012 [11]. The TGAcapped CdTe QDs which has an emission peak at 565nm was chosen for further experiment.
Currently, the most frequently used luciferases in bioimaging are from the firefly, Photinus
pyralis (Fluc), and the sea pansy, Renilla reniformis (Rluc). Compared to Fluc, which is
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ATP dependent, Rluc ATP-independent and is only 36 kDa. Rluc uses coelenterazine as
the substrate, and emits at 480 nm. In addition, its smaller size compared with Fluc (62kDa)
makes it more appropriate for application in bioluminescent system [12]. Currently, the
mutation of native Rluc, Rluc2 or Rluc8, have been used as the luciferase donor to improve
luminescence intensity and stability [5]. However, as the luciferase donor, the sensitivity
of the native Rluc was found to be better than that of Rluc2 or Rluc8 [13]. Therefore, native
Rluc was chosen for the construction of the BRET sensor. As the solution or pH may affect
the efficiency of the catalysis process and the bioluminescence may decay in a short time
[14], the fresh recombinant protein GBP-Rluc was purified and used to test for exploring
the best conditions for generating stable and high intensity bioluminescence.

4.2 Results
4.2.1

Photoluminescence spectra of TGA coated CdTe QDs

It should be noted that NaBH4 played two roles in this reaction. The first part is leading to
a faster reduction of Te4+ to Te2- to supply for the rapid nucleation of QDs. The second is
to supply a protective environment to avoid the oxidation of Te2- during QD growth [15].
Figure 4.1 showed the photoluminescence spectra of the TGA-stabilized CdTe QDs
aqueous solution taken from the refluxing reaction mixture at different intervals of time.
With the prolonging of reflux time, the photoluminescence emission spectra of the CdTe
NCs shifted to longer wavelengths with increasing size of the CdTe NCs as a consequence
of the quantum confinement [11]. The emission of 565 nm was chosen for following
experiments of bioconjugation with protein as the peak is far from the donor peak, which
is at around 470nm, but not too far for detection before decay. Water soluble CdTe NCs
can be direct used for bioconjugation with protein to build potential implant biomaterial as
the proved low toxicity and high biocompatibility. [9]
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Figure 4. 1: The image of the TGA-coated CdTe QDs under an ultraviolet lamp
(top) and the photoluminescence spectra (bottom). The photoluminescence was
at (A) 0.5hr, (B) 1h, (C) 2h, (D) 3 h, (E) 4 h, (F) 5h, (G) 6h.

4.2.2

FTIR spectra of the TGA-stabilized CdTe

To confirm the surface groups of CdTe NCs are carboxylic groups. FTIR was used to
analyse the sample. Fig.4.2 showed the FTIR spectra of the TGA-stabilized CdTe QDs.
Asymmetric and symmetric stretching bands of -COO- located at 1556 and 1378 cm-1,
respectively. The C-O stretch vibrational mode at 1225 cm-1 is also observed in the
spectrum of TGA-QD [16].
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Figure 4. 2: FTIR spectra of TGA-coated CdTe

4.2.3

Protein expression and purification

The theoretical molecular sizes of Rluc and GBP were 36kDa and 33kDa, respectively.
Taking the 6× His-tag, and linker into consideration, the molecular size of the fusion
protein was about 71kDa. Purification of His-Tag proteins are based on the ability of six
consecutive histidine residues on either the N-terminus or carboxyl terminus to bind to a
resin containing nickel ions immobilized by covalently attached nitrilotriacetic acid
(NTA).Based on this mechanism, after washing through the column, the fractions with
different concentrations of imidazole(from 40mM to 120mM) elution buffer were collected.
SDS-PAGE was carried out using the method of Laemmli on an acrylamide gel with 7.5%
resolving gel and 4% stacking gel to identify the protein expression and purification. As
indicated in Fig.4.3, The lanes from right to left were protein makers, frictions washed by
20mM imidazole solution, 40mM imidazole solution, 80mM imidazole solution, 120mM
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imidazole solution and 160mM imidazole solution, respectively. From the SDS-PAGE, the
recombinant protein GBP-Rluc was started to wash out from 80mM (Lane 3) while the
purified protein was washed by 120mM imidazole elution solution.

Figure 4. 3: SDS-PAGE characterization of recombinant protein GBP-Rluc
washing by different concentrations of imidazole elution solution. From right to
left: 1) Protein maker, 2) 20mM imidazole elution solution, 3) 40mM imidazole
elution solution, 4) 80mM imidazole elution solution, 5) 120mM imidazole elution
solution, 6) 160mM imidazole elution solution.
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4.2.4

Optimization for bioluminescence of GBP-RLuc

In order to find the best performance of GBP-Rluc, different concentration of the protein,
substrate and different buffer were tested. Fig. 4.4 showed the bioluminescence of 0.1mg
protein dissolved in 400μL PBS with different amount of CTZ (1mg/ml). The intensity
increased when CTZ increased from 3 to 5μL, while dropped when CTZ kept increasing
to 10μL.

Figure 4. 4: Bioluminescence of 0.1mg protein dissolved in 400μL PBS with 3μl,
5μl, 7μl and 10μl CTZ (1mg/ml), respectively.
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Figure 4. 5: The effect of protein amount to the bioluminescence performance.
Different amount of protein (from 0.01mg to 0.4 mg, all dissolved in 400μl PBS)
were tested with adding 5μl of CTZ (1mg/ml).

Fig.4.5 showed the effect of protein amount to the bioluminescence performance. The
intensity were found to have a slight drop when protein mass increased over 0.2mg. The
behaviour in different buffer: 10 mM Tris/HCl, pH 7.4, 10mM PBS, pH 7.4 and 10mM
Borate, pH 8.0 were tested and the result was shown in Fig. 4.6, which indicates the 10mM
PBS, pH 7.4 is best for the assay. The decay rate of the bioluminescence was measured
with a time interval at 2s, with different amount of protein, as shown in Fig. 4.7. All
measurements were repeated for 3 times.
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Figure 4. 6: Bioluminescence of GBP-Rluc in different buffers: 10 mM Tris/HCl,
pH 7.4, 10mM PBS, pH 7.4 and 10mM Borate, pH 8.0.

51

Figure 4. 7: Luminescence of 0.01 mg, 0.05mg and 0.1mg GBP-Rluc from 0 to
30s at intervals of 1s.

4.3 Conclusion
TGA-coated CdTe was synthesized by using a simple and economical one-pot method. The
highly luminescent water soluble CdTe quantum dots were analyzed by FTIR to insure the
carboxylic groups on the surface for further bioconjugation. GBP-Rluc was purified by histrap column through low imidazole to high imidazole concentration. It was found the high
imidazole elution solution (around 120mM) can wash the target his-tag protein efficiently.
The best conditions for GBP-Rluc to catalyze native CTZ were tested through changing
the ratio of the two components, the buffer and the decay rate with time. The best
performance of GBP-Rluc for catalyzing was found to occur in 10mM PBS, pH 7.4 and
mass ratio is 40 (GBP-Rluc):1 (native CTZ). By measuring the decay of bioluminescence
52

with time, it was found the bioluminescence decreased very quickly especially in the first
4 seconds after adding the native CTZ. This phenomenon indicates the detection should be
started as soon as the substrate is added and mixed homogenously.
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Chapter 5

5

BRET biosensor construction and tear glucose test

TGA coated CdTe QDs with emission peak at 565nm was synthesized and the optimal
performance conditions of GBP-Rluc was tested in chapter 4. In this chapter, the
bioconjugation process of QDs (BRET acceptor) and GBP-Rluc (BRET donor) was
optimized. A gradient concentrations of glucose solution were tested by the BRET
biosensor and two linear relationship between the intensity ratio and the glucose
concentrations were obtained. The rate tear were collected and diluted to certain range and
tested by the BRET biosensor.

5.1 Introduction
As the numbers of diabetes patients increased so fast worldwide, the desire of constructing
glucose sensor especially the non-invasive types have drawn numerous attentions[1]. Body
fluids such as urine [2-4], sweat [5-8] and tear [9-12] thus have been widely used as testing
samples. It has been found that tear glucose level is around 5 times higher in diabetes
patients than in normal people and the tear glucose has been identified to have a positive
correlation with the blood glucose based on previous research[13-15].
In order to test the extremely low concentration of glucose from the tiny amount of the tear
sample, fluorescence resonance energy transfer (FRET) has been used in bioimaging and
biosensing systems because of its high sensitivity for distance change [16-19]. However,
one biggest problem FRET is facing is that the system requires for external illumination to
initiate the fluorescence transfer. This process may lead to background noise and photo
bleaching to the original signal [20]. In order to diminish the drawbacks, Bioluminescence
Resonance Energy Transfer (or BRET) has been developed to make the assay more reliable
[21,22].
Glucose/galactose-binding protein (GGBP) is a bacterial periplasmic-binding protein that
exhibits a hinge motion and results of conformational change upon binding glucose or
galactose molecules [23,24]. Though a lot of research has been done using
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Glucose/galactose binding protein and its mutation to build biosensor for detecting glucose
molecules [25-28], there is no report on the combination of GBP with BRET to our best
knowledge.
The objective of our research is to build a novel glucose sensing system strategy which is
based on the fluorescence changes of the probe as the protein undergoes a structural change
on binding. The recombinant fusion protein consists of bacterial glucose binding protein
(GBP), at the N-terminal and a bioluminescent protein Renilla luciferase (Rluc) at the Cterminal. Afterwards, quantum dots used as the acceptor can be labelled on the N-terminal
of the recombinant protein.

5.2 Results
5.2.1

Optimization of the assay

1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) is a commonly used reagent in
bioconjugation by forming amide bonds. In most cases, the coupling reaction will be better
performed in the presence of EDC at pH between 6 and 8 [29]. However, the excess of
EDC can lead to aggregation after the addition into the solution [30].
To optimal the sensor for glucose detection, Firstly the amount of EDC is fixed to be 20mM,
where the aggregation and precipitation is hardly observed. The ratio between the protein
and quantum dots were tested at 50:1, 150:1, 250:1 and 400:1, respectively and then treated
with 3 μL 0.1mmol/L of aqueous glucose. The BRET intensity ratio IBRET and the intensity
ratio change Ic is defined as follow:
IBRET=IA/ID

Eq.5.1

Ic=(Iw-Ig)/Ig

Eq.5.2

Where IA and ID are the intensity of acceptor and donor, Ig and Iw are the intensity ratio of
the acceptor and donor before and after treated with glucose solution. As EDC mediated
all the amine groups on the surface of GBP-Rluc with the carboxylic groups on the surface
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of CdTe, the bioconjugation process is non-site specific [26,31], the excess amount of
either GBP-Rluc or QDs may affect the sensitivity of this sensor. Fig.5.1 showed the best
sensitivity presents around the ratio at 250:1.

Figure 5. 1: Intensity change with different ratio of GBP-Rluc to QDs. All the test
solutions were treated with 0.1mM glucose.
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Also, the molar ratio of EDC to QDs was also tested at 1000:1, 2500:1 5000:1, 10000:1
and 20000:1. The ratio between GBP-Rluc and QDs is mixed at 250:1 and 3μL of
0.1mmol/L aqueous glucose was added for the test. Though the amount of EDC is key to
mediate the reaction, high concentration of EDC could cause the self-crosslink of proteins
and irreversible precipitation of the products which result in low signal response, as shown
in Fig.5.2. The best ratio between the EDC and the QDs is found to be at 10000:1.

Figure 5. 2: Intensity change with different ratio of EDC to QDs. All the test
solutions were treated with 0.1mM glucose.

5.2.2

Glucose assay and animal tear test

The capability of the nanostructured BRET sensor to measure the concentration of glucose
is evaluated under the above optimized condition. Fig.5.4 showed the BRET spectra with
different concentration of glucose. The increase of glucose concentration results in an
increasing of the BL emission intensity.
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Figure 5. 3: The BRET spectrum with different concentrations of glucose.

According to Eq.5.1, The BL intensity were calculated and the linear relationships between
glucose concentration and the BL intensity are found in the ranges of 0– 0.1mM and 0.2mM
-0.8mM, respectively as shown in Fig.5.4. The limit of detection (LOD) for this assay is
secured to 0.03mM based on 3σ from three independent measurements. The relationship
between the concentration of glucose and the intensity ratio in the two ranges mentioned
above can be expressed as the following equations, respectively.

Y=1.7692X+0.34648

Eq. 5.3
(3)

Y=0.21064X+0.55406

Eq. 5.4
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Figure 5. 4: Linear relationship between BRET intensity ratio of the
designed sensor and the concentration of glucose.

1μL tear samples from 3 rats with different blood glucose levels were diluted to 10μL by
10mM PBS, pH 7.4. The detected signal were calculated by Eq. 5.4 to convert to glucose
level. Table 5.1 shows the tear glucose level measured by BRET sensor and the
corresponding blood glucose level in the three rats.
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Table 5. 1 Glucose level in rats’ tear samples measured through BRET biosensor
compared to the blood glucose level of the three rats

5.3 Conclusion
A novel BRET biosensor for monitoring the tear glucose was developed. CdTe QDs was
used as acceptor and luciferase Rluc was used as the bioluminescence donor. The distance
between the donor and the acceptor is mediated by the folding of GBP, which is at the
upstream of Rluc, with existence of glucose molecules. The ratio of the acceptor (QDs)
and the donor (Rluc) has been observed to increase with the increasing of the glucose
concentration and a similar linear relationship is found both in the range from 0mM to
0.1mM and from 0.2mM to 0.8mM. The limit of detection is as low as 0.03mmol/L. Further,
three rats tear samples with different level of blood glucose were tested by the BRET sensor.
The tear glucose level of normal rat (blood glucose around 5.6mmol/L) was found to be
0.38±0.04mmol/L, while the tear glucose level of diabetes rat (blood glucose at
22.1mmol/L) was found at 1.62± 0.05mmol/L, which is much higher than the normal one
by the measurement of our BRET sensor. Consequently, our designed nanostructured
BRET glucose biosensor could be a promising tool for non-invasively and rapidly detecting
tear glucose.
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Chapter 6

6

Summary and future work

6.1 Summary
As the numbers of diabetes patients increased so fast worldwide, the desire of constructing
glucose sensor especially the non-invasive types have drawn numerous attentions. Body
fluids such as urine sweat and tear thus have been widely used as testing samples. It has
been found that tear glucose level is around 5 times higher in diabetes patients than in
normal people and the tear glucose has been identified to have a positive correlation with
the blood glucose based on previous research. In order to test the extremely low
concentration of glucose from the tiny amount of the tear sample, fluorescence resonance
energy transfer (FRET) has been used in bioimaging and biosensing systems because of its
high sensitivity for distance change. However, one biggest problem FRET is facing is that
the system requires for external illumination to initiate the fluorescence transfer. This
process may lead to background noise and photo bleaching to the original signal. In order
to minimize the drawbacks, Bioluminescence Resonance Energy Transfer (or BRET) has
been developed to make the assay more reliable. This technique uses a bioluminescent
luciferase, typically the luciferase from Renilla reniformis to be the light source.
Glucose/galactose-binding protein (GGBP or GBP) is a bacterial periplasmic-binding
protein that exhibits a hinge motion and results of conformational change upon binding
glucose or galactose molecules. Though a lot of research has been done using
Glucose/galactose binding protein and its mutation to build biosensor for detecting glucose
molecules, there is no report on the combination of GBP with BRET to our best knowledge.
We successfully synthesized a GBP based BRET sensor for non-invasively detecting
glucose molecules. The sensor is made by the bioconjugation of quantum dots and
recombinant protein. The recombinant protein contains the GBP and a bioluminescent
protein, Renilla luciferase (Rluc), used as the donor with the emission peak at 470 nm,
which is able to excite the acceptor of BRET sensor made of cadmium tellurium quantum
dots ( CdTe QDs) with the emission peak at 570 nm. The distance between the BRET pair
depends on the shape of GBP. In the presence of glucose, the conformational change of
GBP leads to the enhanced BRET phenomenon due to the short distance between the BRET
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pair. The quantum dots were chosen as the BRET acceptor due to their tunable emission
peaks by controlling their sizes and bandwidth. The unique optical properties and good
biocompatibility make the QDs very suitable candidates in bioimaging and other
biomedical fields.
In this thesis, TGA-coated CdTe QDs was synthesized by using a simple and economical
one-pot method. The highly luminescent water soluble CdTe QDs were analyzed by FTIR
to insure the carboxylic groups on the surface for further bioconjugation. GBP-Rluc was
purified by his-trap column through low imidazole to high imidazole concentration. It was
found the high imidazole elution solution (around 120mM) can wash the target his-tag
protein efficiently. The best conditions for GBP-Rluc to catalyze native CTZ were tested
through changing the ratio of the two components, the buffer and the decay rate with time.
The best performance of GBP-Rluc for catalyzing was found to occur in 10mM PBS, pH
7.4 and mass ratio is 40 (GBP-Rluc):1 (native CTZ). By measuring the decay of
bioluminescence with time, it was found the bioluminescence decreased very quickly
especially in the first 4 seconds after adding the native CTZ. This phenomenon indicates
the detection should be started as soon as the substrate is added and mixed homogenously
A novel BRET biosensor for monitoring the tear glucose was developed. CdTe QDs was
used as acceptor and luciferase Rluc was used as the bioluminescence donor. The distance
between the donor and the acceptor is mediated by the folding of GBP, which is at the
upstream of Rluc, with existence of glucose molecules. The ratio of the acceptor (QDs)
and the donor (Rluc) has been observed to increase with the increasing of the glucose
concentration and a similar linear relationship is found both in the range from 0M to 0.1
mM and from 0.2mM to 0.8mM. The limit of detection is as low as 0.03mmol/L. Further,
three rats tear samples with different level of blood glucose were tested by the BRET sensor.
The tear glucose level of normal rat (blood glucose around 5.6mmol/L) was found to be
0.38±0.04mmol/L, while the tear glucose level of diabetes rat (blood glucose at
22.1mmol/L) was found at 1.62± 0.05mmol/L, which is much higher than the normal one
by the measurement of our BRET sensor. Consequently, our designed nanostructured
BRET glucose biosensor could be a promising tool for non-invasively detecting tear
glucose.
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6.2 Future work
In this thesis, we constructed the BRET system by bioconjugation the CdTe QDs with
GBP-Rluc, where QDs serve as acceptor, Rluc as donor and GBP as the sensing element
through conformational change. As mentioned the Chapter 2, there are a lot of other
candidates qualified to use as BRET donors. For example, based on the recent development
of NanoLuc luciferase (Nluc), a small (19 kDa), highly stable, ATP independent,
bioluminescent protein, an extremely robust and especially high sensitivity screening
system has been developed whereby primary hits of therapeutic antibodies and antibody
fragments could be characterized and quantified without purification. The smaller size of
Nluc provides unique advantages during bioconjugation process. The sensing element in
the thesis, GBP can be replaced by other glucose affinity proteins like Con.A etc. Also, as
the bioconjugation process is non-specific thus makes the bioconjugation process hard to
maintain. A lot of site-specific methods can be applied to make the system more stable.
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